Cargando…

Ratio of carbon dioxide veno-arterial difference to oxygen arterial-venous difference is not associated with lactate decrease after fluid bolus in critically ill patients with hyperlactatemia: results from a prospective observational study

BACKGROUND: High ratio of the carbon dioxide veno-arterial difference to the oxygen arterial-venous difference (P(va)CO(2)/C(av)O(2)) is associated with fluid bolus (FB) induced increase in oxygen consumption (VO(2)). This study investigated whether P(va)CO(2)/C(av)O(2) was associated with decreases...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaefer, Keitiane, Pierrakos, Charalampos, Nguyen, Thomas, Velissaris, Dimitrios, Attou, Rachid, Devriendt, Jacques, Scolletta, Sabino, Taccone, Fabio Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887917/
https://www.ncbi.nlm.nih.gov/pubmed/36721083
http://dx.doi.org/10.1186/s12871-023-01993-6
Descripción
Sumario:BACKGROUND: High ratio of the carbon dioxide veno-arterial difference to the oxygen arterial-venous difference (P(va)CO(2)/C(av)O(2)) is associated with fluid bolus (FB) induced increase in oxygen consumption (VO(2)). This study investigated whether P(va)CO(2)/C(av)O(2) was associated with decreases in blood-lactate levels FB in critically ill patients with hyperlactatemia. METHODS: This prospective observational study examined adult patients in the intensive care unit (ICU) with lactate levels > 1.5 mmol/L who received FBs. Blood-lactate levels were measured before and after FB under unchanged metabolic, respiratory, and hemodynamic conditions. The primary outcome was blood-lactate levels after FB. Significant decreases in blood-lactate levels were considered as blood-lactate levels < 1.5 mmol/L or a decrease of more than 10% compared to baseline. RESULTS: The study enrolled 40 critically ill patients, and their median concentration of blood lactate was 2.6 [IQR:1.9 − 3.8] mmol/L. There were 27 (68%) patients with P(va)CO(2)/C(av)O(2) ≥ 1.4 mmHg/ml, and 10 of them had an increase in oxygen consumption (dVO(2)) ≥ 15% after FB, while 13 (32%) patients had P(va)CO(2)/C(av)O(2) < 1.4 mmHg/ml before FB, and none of them had dVO(2) ≥ 15% after FB. FB increased the cardiac index in patients with high and low preinfusion P(va)CO(2)/C(av)O(2) (13.4% [IQR: 8.3 − 20.2] vs. 8.8% [IQR: 2.9 − 17.4], p = 0.34). Baseline P(va)CO(2)/C(av)O(2) was not found to be associated with a decrease in blood lactate after FB (OR: 0.88 [95% CI: 0.39 − 1.98], p = 0.76). A positive correlation was observed between changes in blood lactate and baseline P(va)CO(2)/C(av)O(2) (r = 0.35, p = 0.02). CONCLUSIONS: In critically ill patients with hyperlactatemia, P(va)CO(2)/C(av)O(2) before FB cannot be used to predict decreases in blood-lactate levels after FB. Increased P(va)CO(2)/C(av)O(2) is associated with less decrease in blood-lactate levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12871-023-01993-6.